Table 4.
Change in subretinal fluid height, central macular thickness, and best-corrected visual acuity in the crossover group (n = 15 eyes) and retreatment group (n = 8 eyes).
| Mean SRF Height (μm) | Mean CMT (μm) | Mean CCT (μm) | Mean BCVA (LogMAR) | |||||
|---|---|---|---|---|---|---|---|---|
| Crossover Group | Retreatment Group |
Crossover Group | Retreatment Group | Crossover Group | Retreament Group | Crossover Group | Retreatment Group | |
| 6 weeks | 213.4 ± 83.1 | 217.9 ± 128.3 | 330.9 ± 85.7 | 369.6 ± 145.1 | 373.6 ± 83.9 | 344.1 ± 53.5 | 0.20 ± 0.15 | 0.41 ± 0.26 |
| 12 weeks (p-value) |
52.7 ± 82.9 (<0.001 *) |
138.1 ± 48.8 (0.153) | 225.8 ± 62.1 (0.002 *) |
333.8 ± 161.9 (0.474) | 371.0 ± 83.8 (0.535) |
347.1 ± 43.5 (0.730) | 0.16 ± 0.14 (0.028 *) |
0.40 ± 0.28 (0.351) |
* p < 0.05. SRF, subretinal fluid; CMT, central macular thickness; CCT, central choroidal thickness; BCVA, best-corrected visual acuity.